AAAAAA

   
Results: 1-18 |
Results: 18
POPULATION PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA IN VOLUNTEERS ANTICOAGULATED WITH ACENOCOUMAROL
Authors: GIRARD P NONY P ERHARDTSEN E DELAIR S FFRENCH P DECHAVANNE M BOISSEL JP
Citation: P. Girard et al., POPULATION PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA IN VOLUNTEERS ANTICOAGULATED WITH ACENOCOUMAROL, Thrombosis and haemostasis, 80(1), 1998, pp. 109-113
INCIDENCE OF SUBCAPSULAR AND INTRAHEPATIC HEMATOMA FOLLOWING LAPAROSCOPIC LIVER-BIOPSY AFTER INTRAVENOUS FACTOR VIIA ADMINISTRATION IN CIRRHOTIC-PATIENTS WITH COAGULOPATHY
Authors: MENDEZ P ACEBO W JEFFERS L REDDY KR ERHARDTSEN E RASSAM P JAFRI W SOTO E MOLINA E BECH RM SCHIFF ER
Citation: P. Mendez et al., INCIDENCE OF SUBCAPSULAR AND INTRAHEPATIC HEMATOMA FOLLOWING LAPAROSCOPIC LIVER-BIOPSY AFTER INTRAVENOUS FACTOR VIIA ADMINISTRATION IN CIRRHOTIC-PATIENTS WITH COAGULOPATHY, Hepatology, 28(4), 1998, pp. 1551-1551
EFFICACY AND SAFETY OF FFR-RFVIIA IN HEALTHY-VOLUNTEERS
Authors: ERHARDTSEN E THOMSEN MS JOHANNESEN M FALCH JF BECH RM
Citation: E. Erhardtsen et al., EFFICACY AND SAFETY OF FFR-RFVIIA IN HEALTHY-VOLUNTEERS, Circulation, 98(17), 1998, pp. 2967-2967
EFFICACY OF RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN PATIENTS AFFECTED BY VON-WILLEBRAND DISEASE TYPE-III WITH ALLOANTIBODIES AGAINST VON-WILLEBRAND-FACTOR IN ORAL-SURGERY
Authors: SCHIAVONI M VALENZANO E MANGINI F INCHINGOLO F MICELLI M MASCOLO E CIAVARELLA N ERHARDTSEN E HEDNER U
Citation: M. Schiavoni et al., EFFICACY OF RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN PATIENTS AFFECTED BY VON-WILLEBRAND DISEASE TYPE-III WITH ALLOANTIBODIES AGAINST VON-WILLEBRAND-FACTOR IN ORAL-SURGERY, Thrombosis and haemostasis, 1997, pp. 341-341
THE USE OF RECOMBINANT FACTOR VIIA (RFVIIA) IN ADVANCED LIVER-DISEASE
Authors: BERNSTEIN DE JEFFERS LJ ERHARDTSEN E REDDY KR BECH RM HEDNER U SCHIFF ER
Citation: De. Bernstein et al., THE USE OF RECOMBINANT FACTOR VIIA (RFVIIA) IN ADVANCED LIVER-DISEASE, Thrombosis and haemostasis, 1997, pp. 343-343
PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA IN HEALTHY-VOLUNTEERS PRETREATED WITH ACENOCOUMAROL
Authors: ERHARDTSEN E GIRARD P NONY P BECH RM HEDNER U BOISSEL JP
Citation: E. Erhardtsen et al., PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA IN HEALTHY-VOLUNTEERS PRETREATED WITH ACENOCOUMAROL, Thrombosis and haemostasis, 1997, pp. 901-901
RECOMBINANT FACTOR VIIA CORRECTS PROTHROMBIN TIME IN CIRRHOTIC-PATIENTS - A PRELIMINARY-STUDY
Authors: BERNSTEIN DE JEFFERS L ERHARDTSEN E REDDY KR GLAZER S SQUIBAN P BECH R HEDNER U SCHIFF ER
Citation: De. Bernstein et al., RECOMBINANT FACTOR VIIA CORRECTS PROTHROMBIN TIME IN CIRRHOTIC-PATIENTS - A PRELIMINARY-STUDY, Gastroenterology, 113(6), 1997, pp. 1930-1937
THE EFFECT OF RECOMBINANT FACTOR VIIA (RFVIIA) ON THE HEMATOLOGICAL PARAMETERS OF DIFFUSE INTRAVASCULAR COAGULATION (DIC) IN CIRRHOTIC-PATIENTS (PTS)
Authors: BERNSTEIN DE GLAZER S JEFFERS LJ REDDY KR SQUIBAN P BECH RN ROACH K SEALE R ERHARDTSEN E SCHIFF ER
Citation: De. Bernstein et al., THE EFFECT OF RECOMBINANT FACTOR VIIA (RFVIIA) ON THE HEMATOLOGICAL PARAMETERS OF DIFFUSE INTRAVASCULAR COAGULATION (DIC) IN CIRRHOTIC-PATIENTS (PTS), Hepatology, 23(1), 1996, pp. 8-8
BLOCKING OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) SHORTENS THE BLEEDING-TIME IN RABBITS WITH ANTIBODY-INDUCED HEMOPHILIA-A
Authors: ERHARDTSEN E EZBAN M MADSEN MT DINESS V GLAZER S HEDNER U NORDFANG O
Citation: E. Erhardtsen et al., BLOCKING OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) SHORTENS THE BLEEDING-TIME IN RABBITS WITH ANTIBODY-INDUCED HEMOPHILIA-A, Blood coagulation & fibrinolysis, 6(5), 1995, pp. 388-394
FURTHER SAFETY INFORMATION ON THE USE OF FACTOR-VIIA (RFVIIA) IN ACENOCOUMAROL TREATED VOLUNTEERS - A PHASE-1 STUDY
Authors: ERHARDTSEN E NONY P FFRENCH P DECHAVANNE M BOISSEL JP HANSEN LL HEDNER U GLAZER S
Citation: E. Erhardtsen et al., FURTHER SAFETY INFORMATION ON THE USE OF FACTOR-VIIA (RFVIIA) IN ACENOCOUMAROL TREATED VOLUNTEERS - A PHASE-1 STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 984-984
DOSE-EFFECT RELATIONS OF RECOMBINANT FACTOR-VIIA (RFVIIA) IN HEALTHY-SUBJECTS PRETREATED WITH ACENOCOUMAROL
Authors: FFRENCH P NONY P ERHARDTSEN E DELAIR S GIRARD P DECHAVANNE M BOISSEL JP GLAZER S
Citation: P. Ffrench et al., DOSE-EFFECT RELATIONS OF RECOMBINANT FACTOR-VIIA (RFVIIA) IN HEALTHY-SUBJECTS PRETREATED WITH ACENOCOUMAROL, Thrombosis and haemostasis, 73(6), 1995, pp. 984-984
THE EFFECT ON CLOT PREVENTION BY LOGIPARIN AND RECOMBINANT APROTININ
Authors: ERHARDTSEN E KRISTENSEN H DINESS V HEDNER U
Citation: E. Erhardtsen et al., THE EFFECT ON CLOT PREVENTION BY LOGIPARIN AND RECOMBINANT APROTININ, Thrombosis and haemostasis, 73(6), 1995, pp. 1333-1333
EFFECTS OF ACENOCOUMAROL TREATMENT ON HUMAN PLASMA FACTOR-VII
Authors: PERSSON E EZBAN M NICOLAISEN EM ERHARDTSEN E HEDNER U
Citation: E. Persson et al., EFFECTS OF ACENOCOUMAROL TREATMENT ON HUMAN PLASMA FACTOR-VII, Thrombosis and haemostasis, 73(6), 1995, pp. 1404-1404
RECOMBINANT VIIA (RFVLLA) IN THE TREATMENT OF PROLONGED PROTHROMBIN TIMES (PT) IN CIRRHOTICS
Authors: BERNSTEIN DE GLAZER S JEFFERS LJ SQUIBAN P REDDY KR ROACH K SEALE R ERHARDTSEN E SCHIFF ER
Citation: De. Bernstein et al., RECOMBINANT VIIA (RFVLLA) IN THE TREATMENT OF PROLONGED PROTHROMBIN TIMES (PT) IN CIRRHOTICS, Hepatology, 22(4), 1995, pp. 730-730
THE EFFECT OF RECOMBINANT APROTININ ON T-PA-INDUCED BLEEDING IN RATS
Authors: ERHARDTSEN E BREGENGAARD C HEDNER U DINESS V HALKJAER E PETERSEN LC
Citation: E. Erhardtsen et al., THE EFFECT OF RECOMBINANT APROTININ ON T-PA-INDUCED BLEEDING IN RATS, Blood coagulation & fibrinolysis, 5(5), 1994, pp. 707-712
THE SAFETY OF RECOMBINANT FACTOR-VIIA (RFVIIA) IN ACENOCOUMAROL TREATED VOLUNTEERS - A PHASE-1 STUDY
Authors: ERHARDTSEN E NONY P FFRENCH P DECHAVANNE M BOISSEL JP LYNG HL HEDNER U GLAZER S
Citation: E. Erhardtsen et al., THE SAFETY OF RECOMBINANT FACTOR-VIIA (RFVIIA) IN ACENOCOUMAROL TREATED VOLUNTEERS - A PHASE-1 STUDY, Blood, 84(10), 1994, pp. 10000067-10000067
BLOCKING OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) SHORTENS THE BLEEDING-TIME IN RABBITS WITH ANTIBODY-INDUCED HEMOPHILIA-A
Authors: ERHARDTSEN E MADSEN MT EZBAN M HEDNER U DINESS V GLAZER S NORDFANG O
Citation: E. Erhardtsen et al., BLOCKING OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) SHORTENS THE BLEEDING-TIME IN RABBITS WITH ANTIBODY-INDUCED HEMOPHILIA-A, Thrombosis and haemostasis, 69(6), 1993, pp. 556-556
THE EFFECT OF APROTININ ON A T-PA INDUCED BLEEDING - A DOSE-RESPONSE STUDY IN RATS
Authors: ERHARDTSEN E BREGENGARD C PETERSEN LC DINESS V HEDNER U HALDKJAER E
Citation: E. Erhardtsen et al., THE EFFECT OF APROTININ ON A T-PA INDUCED BLEEDING - A DOSE-RESPONSE STUDY IN RATS, Thrombosis and haemostasis, 69(6), 1993, pp. 590-590
Risultati: 1-18 |